Upcoming Carter Symposium

Date/Time – April 29, 2024 @ 1:00 PM – 5:00 PM EST
Location – Med Ed Building, Auditorium 3110

Title: Cancer Immunology: from insights to innovations
Speakers: Dr. Padmanee Sharma, MD, PhD, University of Texas MD Anderson Cancer Center, “Integrating clinical and laboratory research to identify mechanisms of response and resistance to immune checkpoint therapy”
Dr. Tyler Jacks, PhD, Massachusetts Institute of Technology, “Investigating tumor-immune dynamics using genetically engineered mouse models of cancer”
Dr. Ellen Pure, PhD, University of Pennsylvania, “Immune status and stromal niches in solid tumors”
Dr. Elizabeth Jaffee, MD, John Hopkins Medicine, “Cancer immunotherapy in the era of precision medicine”

Past Carter Symposiums

Past Anderson Symposiums

Before the Carter Symposium we had the Anderson Symposium.

The John F. Anderson Memorial Lectureship was established in 1955 by Dr. John F. Anderson, a graduate in 1895 of the University of Virginia School of Medicine. Through his most generous gift to the University, it has been possible to establish a lectureship in medical science and public health, which will bring to this medical community, the latest developments in these fields.

2003 — Initiation and Regulation of the Immune Response

(Chair, Kodi Ravichandran)
Chris Bleackley, PhD, FRSC The University of Alberta Viruses and attack of the killer T cells.
Stephen C. Jameson, PhD University of Minnesota Self awareness in T cell regulation.
Ann Marshak-Rothstein, PhD Boston University School of Medicine Complex activation of systemic autoimmune disease.
Pamela L. Schwartzberg, MD, PhD National Human Genome Research Institute T lymphocyte signaling and function2002 — Plagues of the 21st Century: HIV, Viral Hepatitis, Tuberculosis, and Malaria.

(Chair, Dean Kedes, MD, PhD)
Harvey J. Alter, MD, FACP Dept. Transfusion Medicine, NIH Natural History of Hepatitis C.
Beatrice H. Hahn, MD University of Alabama at Birmingham Prevalence, Distribution, and Diversity of SIVcpz in Wild Chimpanzees.
William Jacobs, Jr., PhD Albert Einstein College of Medicine Tuberculosis Vaccines.
Louis H. Miller, MD Head, Malaria Vaccine Development Unit, NIH Malaria Pathogenesis to Vaccine Development.
Duane J. Osheim, PhD University of Virginia Renaissance Plagues in an Age of Emerging Diseases.

2001 — Viral Pathogenesis and Immunity

(Chair, David Camerini)
Robert Wagner, MD, University of Virginia, A Largely Personal Half-Century Perspective of Virology.
George Miller, MD, Yale University School of Medicine, Switch between Latency and Lytic Cycle of Epstein-Barr Virus and Kaposi’s Sarcoma Herpes virus.
Eckard Wimmer, PhD, State University of New York @ Stony Brook, Determinants of Neurovirulence: Can Poliovirus be Harnessed for the Treatment of Human Brain Tumors.
Ron Swanstrom, PhD University of North Carolina @ Chapel Hill HIV Evolution as a Probe for Virus-Host Interactions.
Brigitte Autran, MD, PhD, Hospital Pitie-Salpetriere, Immune Reconstruction and Rationale for Immune-Based Intervention in HIV Infection.
Andrew McMichael, F.R.S., PhD, The John Radcliffe Hospital, The Battle Between HIV and the Immune System.

2000 — Infection and Immunity: Where are we and Where are we going?

(Chair, Ulrike Lorenz)
Rafi Ahmed, PhD Emory University Immunological memory to viruses.
Thomas J. Braciale, MD, PhD, University of Virginia, Paradigms and paradoxes in the host response to Respiratory Syncytial Virus
Stefanie Vogel, PhD Uniformed Services University of Health Sciences, The role of macophage and macrophage-deceived mediators in gram negative sepsis: where we are and where we’re going.
Stephen Lory, PhD, University of Washington, DNA microassays as tools for understanding host-pathogen interactions 1998 — Interaction with the Host.

(Chair, Joanna Goldberg)
Diane Griffin, MD, PhD, John Hopkins School of Hygiene/Public Health, Measles and the role of the immune response in disease.
Arturo Casadevall, MD, PhD, Albert Einstein College of Medicine, Cryptococcus neoformans: host cell-fungus interactions provide new insights into mechanisms of pathogenesis and host defense.
Brett Finlay, PhD, University of British Columbia, Enteric pathogen interactions with host cells.
Alan Sher, PhD, National Institutes of Health, Initiation and regulation of host resistance to an intracellular pathogen, Toxoplasma gondii.

1997 — Intracellular Parasitism: Entry and Survival

(Chair, Tim Bender)
Robert Doms, MD, PhD, University of Pennsylvania. Unwelcome guests with master keys: How HIV-1 uses chemokine receptors for cellular entry.
Daniel Portnoy, PhD, University of California, Berkeley, How Listeria monocytogenes enters the cytosol and exploits a host system of actin-based motility to move from cell to cell.
Hidde Ploegh, PhD, Massachusetts Institute of Technology, Viral evasion of the immune system.
David Russell, MD, PhD, Washington University, Mycobacterium, a bitter pill to phagocytose.